Abstract
Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults, characterized by a high mortality rate and ineffective treatment options. In this scenario, CAR-T cells are considered one of the most promising emerging treatments for GBM, due to their specificity against the tumor. However, in vitro study models that accurately simulate the complex tumor conditions in…